Literature DB >> 33811109

Report from the European Society of Gynaecological Oncology (ESGO) 2020 State-of-the-Art Virtual Meeting.

Zoia Razumova1, Nicolò Bizzarri2, Joanna Kacperczyk-Bartnik3, Andrei Pletnev4, Antonio Gonzalez Martin5, Jan Persson6,7.   

Abstract

This is a report from the European Society of Gynaecological Oncology State-of-the-Art Virtual Meeting held December 14-16, 2020. The unique 3-day conference offered comprehensive state-of-the-art summaries on the major advances in the treatment of different types of gynecological cancers. Sessions opened with a case presentation followed by a keynote lecture and interactive debates with opinion leaders in the field. The speakers also presented scientific reviews on the clinical trial landscape in collaboration with the European Network of Gynecological Oncological Trial (ENGOT) groups. In addition, the new ESGO-ESRTO-ESP endometrial cancer guidelines were officially presented in public. This paper describes the key information and latest studies that were presented for the first time at the conference. © IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cervical cancer; miscellaneous; ovarian cancer; uterine cancer; vulvar and vaginal cancer

Mesh:

Year:  2021        PMID: 33811109     DOI: 10.1136/ijgc-2021-002577

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  1 in total

1.  Clinical Profile and Survival Outcome of Endometrial Cancer with p53 Mutation.

Authors:  Anila Tresa; Suchetha Sambasivan; P Rema; Dhanya Dinesh; J Sivaranjith; Sindhu P Nair; Aleyamma Mathew; J V Ammu; Aswin Kumar
Journal:  Indian J Surg Oncol       Date:  2022-03-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.